(PFGC) Performance Food - Overview
Stock: Foodservice, Convenience, Specialty
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 41.3% |
| Relative Tail Risk | -8.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | -6.12 |
| Character TTM | |
|---|---|
| Beta | 0.782 |
| Beta Downside | 0.895 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.24% |
| CAGR/Max DD | 0.81 |
Description: PFGC Performance Food January 03, 2026
Performance Food Group Company (PFGC) distributes a broad portfolio of food and related products across North America through three operating segments-Foodservice, Convenience, and Specialty. Its catalogue spans fresh proteins (beef, pork, poultry, seafood), frozen and refrigerated items, dry groceries, cleaning supplies, snacks, beverages, health-and-beauty goods, and even nicotine products, supported by an extensive network of distribution centers and value-added services such as menu development, procurement assistance, and technology-enabled marketing programs.
Key industry drivers that influence PFGC’s outlook include: (1) **Foodservice inflation**, where rising commodity prices and labor costs have historically pressured margins but also create pricing power for distributors that can offer cost-saving solutions; (2) **Same-store sales growth**-PFGC has reported a 4-5% YoY increase in its core Foodservice segment in recent quarters, reflecting steady demand from independent and chain restaurants; and (3) **E-commerce penetration**, with the company expanding digital ordering platforms that have accelerated order frequency and improved inventory turnover, a trend seen across the broader food-distribution sector.
For a deeper, data-driven look at how these factors translate into valuation metrics, you might explore the analytics on ValueRay to see where the risk-adjusted upside may lie.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 345.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.23 > 1.0 |
| NWC/Revenue: 4.19% < 20% (prev 4.59%; Δ -0.40% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.29b > Net Income 345.1m |
| Net Debt (7.95b) to EBITDA (1.25b): 6.38 < 3 |
| Current Ratio: 1.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.8m) vs 12m ago 0.32% < -2% |
| Gross Margin: 11.87% > 18% (prev 0.11%; Δ 1176 % > 0.5%) |
| Asset Turnover: 372.8% > 50% (prev 351.5%; Δ 21.30% > 0%) |
| Interest Coverage Ratio: 2.16 > 6 (EBITDA TTM 1.25b / Interest Expense TTM 400.3m) |
Altman Z'' 1.78
| A: 0.15 (Total Current Assets 7.37b - Total Current Liabilities 4.62b) / Total Assets 18.18b |
| B: 0.10 (Retained Earnings 1.80b / Total Assets 18.18b) |
| C: 0.05 (EBIT TTM 863.7m / Avg Total Assets 17.64b) |
| D: 0.13 (Book Value of Equity 1.80b / Total Liabilities 13.53b) |
| Altman-Z'' Score: 1.78 = BBB |
Beneish M -3.15
| DSRI: 0.93 (Receivables 2.73b/2.69b, Revenue 65.77b/60.10b) |
| GMI: 0.97 (GM 11.87% / 11.49%) |
| AQI: 0.92 (AQ_t 0.29 / AQ_t-1 0.32) |
| SGI: 1.09 (Revenue 65.77b / 60.10b) |
| TATA: -0.05 (NI 345.1m - CFO 1.29b) / TA 18.18b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of PFGC shares?
Over the past week, the price has changed by -1.10%, over one month by +7.92%, over three months by -0.60% and over the past year by +8.31%.
Is PFGC a buy, sell or hold?
- StrongBuy: 7
- Buy: 3
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PFGC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 117.5 | 24.4% |
| Analysts Target Price | 117.5 | 24.4% |
| ValueRay Target Price | 107.3 | 13.7% |
PFGC Fundamental Data Overview February 07, 2026
P/E Forward = 17.331
P/S = 0.227
P/B = 3.0313
P/EG = 0.6659
Revenue TTM = 65.77b USD
EBIT TTM = 863.7m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 5.27b USD (from longTermDebt, last quarter)
Short Term Debt = 351.4m USD (from shortTermDebt, last quarter)
Debt = 7.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.95b USD (from netDebt column, last quarter)
Enterprise Value = 22.10b USD (14.16b + Debt 7.99b - CCE 41.0m)
Interest Coverage Ratio = 2.16 (Ebit TTM 863.7m / Interest Expense TTM 400.3m)
EV/FCF = 27.88x (Enterprise Value 22.10b / FCF TTM 792.7m)
FCF Yield = 3.59% (FCF TTM 792.7m / Enterprise Value 22.10b)
FCF Margin = 1.21% (FCF TTM 792.7m / Revenue TTM 65.77b)
Net Margin = 0.52% (Net Income TTM 345.1m / Revenue TTM 65.77b)
Gross Margin = 11.87% ((Revenue TTM 65.77b - Cost of Revenue TTM 57.96b) / Revenue TTM)
Gross Margin QoQ = 11.96% (prev 11.81%)
Tobins Q-Ratio = 1.22 (Enterprise Value 22.10b / Total Assets 18.18b)
Interest Expense / Debt = 1.31% (Interest Expense 104.5m / Debt 7.99b)
Taxrate = 28.84% (25.0m / 86.7m)
NOPAT = 614.7m (EBIT 863.7m * (1 - 28.84%))
Current Ratio = 1.60 (Total Current Assets 7.37b / Total Current Liabilities 4.62b)
Debt / Equity = 1.72 (Debt 7.99b / totalStockholderEquity, last quarter 4.65b)
Debt / EBITDA = 6.38 (Net Debt 7.95b / EBITDA 1.25b)
Debt / FCF = 10.02 (Net Debt 7.95b / FCF TTM 792.7m)
Total Stockholder Equity = 4.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.96% (Net Income 345.1m / Total Assets 18.18b)
RoE = 7.66% (Net Income TTM 345.1m / Total Stockholder Equity 4.51b)
RoCE = 8.83% (EBIT 863.7m / Capital Employed (Equity 4.51b + L.T.Debt 5.27b))
RoIC = 6.18% (NOPAT 614.7m / Invested Capital 9.94b)
WACC = 5.96% (E(14.16b)/V(22.14b) * Re(8.80%) + D(7.99b)/V(22.14b) * Rd(1.31%) * (1-Tc(0.29)))
Discount Rate = 8.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.35%
[DCF Debug] Terminal Value 88.21% ; FCFF base≈689.9m ; Y1≈851.0m ; Y5≈1.45b
Fair Price DCF = 212.5 (EV 41.33b - Net Debt 7.95b = Equity 33.39b / Shares 157.1m; r=5.96% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 43.14 | EPS CAGR: 19.03% | SUE: -1.68 | # QB: 0
Revenue Correlation: 83.69 | Revenue CAGR: 6.30% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.196 | Revisions Net=-1 | Analysts=9
EPS current Year (2026-06-30): EPS=4.76 | Chg30d=-0.216 | Revisions Net=+0 | Growth EPS=+6.2% | Growth Revenue=+6.8%
EPS next Year (2027-06-30): EPS=6.03 | Chg30d=-0.221 | Revisions Net=+0 | Growth EPS=+26.8% | Growth Revenue=+6.6%